一个由人工智能驱动的多病态框架揭示了阿尔茨海默病,肌缩侧面硬化症和前性痴呆症中共享的代谢和免疫核心
Meghna R Iyer1, Benjamin Zhao1, Xin He1
1Laboratory for Pathology Dynamics, Department of Biomedical Engineering, Georgia Institute of Technology & Emory University School of Medicine, Atlanta, GA 30332, USA.
Biomedicines
|February 27, 2026
概括
阿尔茨海默病 (AD),ALS和FTD有着共同的代谢和免疫核心,具有不同的途径影响疾病脆弱性. 人工智能分析揭示了神经退行性疾病的统一多病态框架.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 基因组学就是基因组学.
背景情况:
- 阿尔茨海默病 (AD),肌缩侧面硬化症 (ALS) 和前性痴呆症 (FTD) 具有共同的分子病理,但具有不同的临床表现.
- 了解共享和特定疾病的多病态架构对于神经退行性疾病研究至关重要.
研究的目的:
- 描述AD,ALS和FTD的共享和疾病特定的多病态架构.
- 用人工智能驱动的基于文献的语义网络进行全面分析.
主要方法:
- 将SemNet 2.0应用于超过3500万个PubMed摘要,分析疾病/综合征 (DSYN) 和药理物质 (PHSU) 节点.
- 使用HeteSim对节点进行排名,并将它们映射到一个13类机械主义本体学.
- 量化了疾病交叉点,丰富了本体学,排名相似性,并构建了一个多重病态优先景观.
主要成果:
- 确定了一个融合的多病态架构,在AD,ALS和FTD之间共享代谢和免疫核心.
- 揭示了特定疾病的特征:在AD中心血管,在ALS中神经肌肉/毒素,在FTD中神经行为代谢.
- PHSU模式表明针对炎症,代谢或神经调节过程的向化合物.
结论:
- 将AD,ALS和FTD定位在一个统一的AI衍生多病症框架内.
- 这种本体学引导的方法支持对生物标志物发现,风险分层和神经退行性疾病的跨疾病治疗探索进行假设生成.
相关概念视频
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Dementia
609
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
609
Amyloid Fibrils
12.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.2K
Amyloid Fibrils
6.8K
6.8K


